assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
Published 8 years ago • 244 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:04
molecular testing in egfr mutant driven nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
1:02
blood tests for identifying and monitoring alk-positive non-small cell lung cancer
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
4:28
mutation testing for advanced lung cancer
-
9:30
egfr testing for nsclc
-
7:07
mutation testing in nsclc
-
1:41
physician perceptions of testing practices in patients with egfr mutated nsclc
-
4:12
clinical utility of liquid biopsy for egfr mutation
-
2:19
dr. wakelee on detection of egfr t790m mutation in nsclc
-
1:41
egfr mutations in patients with lung cancer
-
20:34
2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:05
first line egfr based therapy for advanced squamous non small cell lung cancer nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
2:14
lux-lung 7: phase 2b trial of first-line afatinib versus gefitinib for egfr mutation-positive nsclc